Long-Term Disease Control of a Non-Operable Neuroendocrine Tumor of the Lung with Lanreotide: A Case Study von Van Fraeyenhove, F., De Droogh, E., Meireson, N., Galdermans, D., Goor, C., Van Acker, F., Mattelaer, C., De Ruyter, V., Schrijvers, D.

Volltext

Long-term disease control of a non-operable neuroendocrine tumor of the lung with lanreotide: a case study von Van Fraeyenhove, F, De Droogh, E, Meireson, N, Galdermans, D, Goor, C, Van Acker, F, Mattelaer, C, De Ruyter, V, Schrijvers, D

Volltext

OC-0682: Phase 1 trial of pembrolizumab with SBRT in metastatic urothelial carcinoma von Sundahl, N., Rottey, S., Decaestecker, K., De visschere, P., De maeseneer, D., Reynders, D., Meireson, A., Goetghebeur, E., Fonteyne, V., Verbeke, S., Brochez, L., Ost, P.

Volltext

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results von Ost, P., Sundahl, N., Vandekerkhove, G., Decaestecker, K., Meireson, A., De Visschere, P., Fonteyne, V., De Maeseneer, D., Reynders, D., Goetghebeur, E., Van Dorpe, J., Verbeke, S., Annala, M., Brochez, L., Van Der Eecken, K., Wyatt, A.W., Rottey, S.

Volltext

PT324 - Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational... von Ost, P., Sundahl, N., Vandekerkhove, G., Decaestecker, K., Meireson, A., De Visschere, P., Fonteyne, V., De Maeseneer, D., Reynders, D., Goetghebeur, E., Van Dorpe, J., Verbeke, S., Annala, M., Brochez, L., Van Der Eecken, K., Wyatt, A.W., Rottey, S.

Volltext

Method and device for determining the color appearance of color overprints von Van de Capelle, Jean-Pierre, Meireson, Baldewin

Volltext bestellen